13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2021. See the latest, Q2 2026 →
Reported value
$408.71B
+6.1% on the quarter before
Positions
425
44 new · 23 sold out
Top 10
28.5%
of the value
Est. gain
+$18.85B
on stocks held all quarter
Est. return
+5.3%
on those stocks since Q4 2020
Positions as of Mar 31, 2021, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 47% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2020. Striped tiles are options.
Largest buys
Since Q4 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jpmorgan Chase & Co~$1.17BAdded · 1.2% → 1.7%+7,690,849 shares
- Vale S A~$925.4MAdded · 0.9% → 1.1%+53,246,270 shares
- Microsoft~$891.4MAdded · 5.5% → 5.7%+3,780,811 shares
- Comcast Corp New~$850.5MAdded · 1.6% → 1.8%+15,718,505 shares
- Micron~$788.3MAdded · 0.1% → 0.3%+8,936,847 shares
- Citigroup Inc~$783.5MAdded · 0.5% → 0.8%+10,769,748 shares
- Conocophillips~$762.9MAdded · 0.1% → 0.3%+14,403,035 shares
- MercadoLibre~$689.4MAdded · 1.3% → 1.2%+468,294 shares
- Bilibili Inc~$667.7MAdded · 0.1% → 0.3%+6,237,082 shares
- Toronto Dominion Bk Ont~$664.5MAdded · 0.5% → 0.7%+10,188,552 shares
Largest sells
Since Q4 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$3.19BCut · 3.4% → 2.7%−10,820,747 shares
- Abbvie Inc~$1.92BCut · 1.1% → 0.5%−17,700,423 shares
- Broadcom~$1.22BCut · 3.7% → 3.4%−2,638,854 shares
- Unitedhealth Group Inc~$1.08BCut · 2.0% → 1.7%−2,906,998 shares
- United Parcel Service Inc~$985.4MCut · 0.4% → 0.2%−5,796,873 shares
- Netflix~$885.4MCut · 4.2% → 3.6%−1,697,248 shares
- Apple~$786.5MCut · 1.1% → 0.7%−6,439,139 shares
- Johnson Ctls Intl Plc~$784.6MCut · 0.2% → 0.0%−13,148,839 shares
- Amazon~$778.4MCut · 3.3% → 2.8%−251,594 shares
- Coca Cola Co~$621.0MCut · 0.4% → 0.2%−11,782,084 shares
Holdings
As of Mar 31, 2021. Changes are in shares against Dec 31, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +4.0% · price +6.0% | 5.7% | $23.41B | +$1.27B | ||||||||
| NetflixCOM · shares −5.6% · price −3.5% | 3.6% | $14.89B | −$544.1M | ||||||||
| BroadcomCOM · shares −8.1% · price +5.9% | 3.4% | $13.83B | +$769.8M | ||||||||
| AmazonCOM · shares −6.4% · price −5.0% | 2.8% | $11.45B | −$602.8M | ||||||||
| MetaCL A · shares −22% · price +7.8% | 2.7% | $11.13B | +$807.8M | ||||||||
| Abbott LabsCOM · shares −0.7% · price +9.5% | 2.5% | $10.28B | +$888.0M | ||||||||
| AlphabetCAP STK CL A · shares +6.1% · price +17.7% | 2.0% | $8.25B | +$1.17B | ||||||||
| Amgen IncCOM · shares +2.7% · price +8.2% | 2.0% | $8.12B | +$600.0M | ||||||||
| Gilead Sciences IncCOM · shares +0.8% · price +10.9% | 1.9% | $7.92B | +$775.1M | ||||||||
| Comcast Corp NewCL A · shares +13% · price +3.3% | 1.8% | $7.29B | +$203.7M | ||||||||
| Unitedhealth Group IncCOM · shares −13% · price +6.1% | 1.7% | $7.09B | +$407.6M | ||||||||
| MastercardCL A · shares +3.3% · price −0.2% | 1.7% | $6.92B | −$16.7M | ||||||||
| Jpmorgan Chase & CoCOM · shares +20% · price +19.8% | 1.7% | $6.91B | +$948.7M | ||||||||
| AlphabetCAP STK CL C · shares +9.0% · price +18.1% | 1.6% | $6.54B | +$919.1M | ||||||||
| General Mtrs CoCOM · shares +12% · price +38.0% | 1.4% | $5.82B | +$1.43B | ||||||||
| Philip Morris Intl IncCOM · shares −1.9% · price +7.2% | 1.4% | $5.63B | +$377.2M | ||||||||
| Home Depot IncCOM · shares +1.2% · price +14.9% | 1.3% | $5.20B | +$666.9M | ||||||||
| Eog Res IncCOM · shares +0.9% · price +45.4% | 1.3% | $5.17B | +$1.60B | ||||||||
| MercadoLibreCOM · shares +16% · price −12.1% | 1.2% | $4.94B | −$586.2M | ||||||||
| Csx CorpCOM · shares −2.9% · price +6.2% | 1.2% | $4.88B | +$286.9M | ||||||||
| Vale S ASPONSORED ADS · shares +25% · price +3.7% | 1.1% | $4.69B | +$134.2M | ||||||||
| Canadian Nat Res LtdCOM · shares +2.8% · price +28.6% | 1.1% | $4.38B | +$949.1M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −11% · price −2.0% | 0.99% | $4.04B | −$83.2M | ||||||||
| Linde PlcSHS · shares +0.5% · price +6.4% | 0.97% | $3.97B | +$236.7M | ||||||||
| Raytheon Technologies CorpCOM · shares +9.3% · price +8.1% | 0.94% | $3.85B | +$262.5M | ||||||||
| Total · 425 positions | 100% | $408.71B | +$18.85B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2020 to Q1 2021: 381 stocks held throughout, up $18.85B (+5.3%).
- Eog Res Inc+$1.60B+45%
- General Mtrs Co+$1.43B+38%
- Microsoft+$1.27B+6%
- Alphabet+$1.17B+18%
- Canadian Nat Res Ltd+$949.1M+29%
- Netflix−$544.1M−4%
- MercadoLibre−$586.2M−12%
- Amazon−$602.8M−5%
- Stoneco Ltd−$633.2M−27%
- Sarepta Therapeutics Inc−$742.4M−56%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |